Business Context and Reporting Period
This Form 8-K filing by The LGL Group, Inc. (LGL) reports on events occurring on January 16, 2026, with the report filed on January 22, 2026. The filing addresses Item 5.02 regarding changes to the compensatory arrangements for Marc Gabelli, the Company's Executive Chairman of the Board.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation adjustments.
Material Changes
The Board of Directors approved the following changes to Mr. Gabelli's compensation, effective January 1, 2026:
- Base Salary: An annual base salary of $250,000, allocated equally among his roles and subject to annual review.
- 100,000 Option Grant: Stock options to purchase 100,000 shares under the 2021 Incentive Plan with an exercise price equal to the fair market value on the grant date. Vesting is 60% immediate, 20% on the first anniversary, and 20% on the second anniversary.
- One-Time Equity Award:
- 50,000 Option Grant: Options to purchase 50,000 shares with an exercise price at 120% of the fair market value on the grant date, vesting immediately.
- 50,000 Restricted Stock Grant: 50,000 shares of restricted common stock vesting in three equal tranches (1/3 immediate, 1/3 on the first anniversary, 1/3 on the second anniversary).
- Benefits: Eligibility to participate in benefit plans and perquisites generally available to executive officers.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on business outlook, or discussion of specific risks and contingencies beyond the standard qualification that the description is subject to the terms of the applicable award agreements and the Plan.
Investor Verification Checklist
- Verify the fair market value of LGL common stock on January 16, 2026, to determine the exercise price for the 100,000 option grant.
- Confirm the total dilution impact of the 200,000 new equity instruments (150,000 options and 50,000 restricted shares) on outstanding share count.
- Review the Company's 2021 Incentive Plan to ensure sufficient shares remain available for these grants.
- Assess the immediate expense recognition impact of the 60% immediate vesting on the 100,000 option grant and the 1/3 immediate vesting on the restricted stock.